← Back to Search

Other

MeRT for Post-Traumatic Stress Disorder (MeRT-005-B Trial)

N/A
Recruiting
Led By James Chung, DO
Research Sponsored by Wave Neuroscience
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 - 65 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 6 months
Awards & highlights

MeRT-005-B Trial Summary

This trial will test whether Biometrics-guided Magnetic e-Resonance Therapy is a safe and effective treatment for PTSD and PPCS following TBI.

Who is the study for?
This trial is for adults aged 18-65 with PTSD, diagnosed per DSM-V criteria and a PCL-5 score of at least 30. Participants must have had symptoms for over six months. Exclusions include those with severe brain injuries, neurological disorders, recent participation in other trials, certain medication use, metal implants affected by magnets, significant medical conditions or substance abuse issues.Check my eligibility
What is being tested?
The study tests the safety and effectiveness of Magnetic e-Resonance Therapy (MeRT) on individuals with PTSD after Traumatic Brain Injury (TBI). It compares active MeRT treatment to a sham (placebo-like) procedure to see if there's an improvement in PTSD symptoms.See study design
What are the potential side effects?
While not explicitly listed here, potential side effects may include discomfort at the treatment site, headaches or dizziness due to magnetic stimulation. More serious risks could involve seizures or changes in mood or behavior.

MeRT-005-B Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.

MeRT-005-B Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in PTSD Symptoms
Secondary outcome measures
Change in PPCS
Other outcome measures
Safety Outcomes - Incidents and types of adverse events

MeRT-005-B Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active MeRT TreatmentActive Control1 Intervention
Active treatment will consist of 6 seconds a minute for 30 minutes a day, 5 days a week for 5 weeks.
Group II: Sham MeRT TreatmentPlacebo Group1 Intervention
Sham treatment will consist of 6 seconds a minute for 30 minutes a day, 5 days a week for 5 weeks.

Find a Location

Who is running the clinical trial?

Peachtree BioResearch SolutionsUNKNOWN
1 Previous Clinical Trials
50 Total Patients Enrolled
Wave NeuroscienceLead Sponsor
12 Previous Clinical Trials
764 Total Patients Enrolled
Texas A&M UniversityOTHER
138 Previous Clinical Trials
23,283 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current participation rate in this clinical research?

"Affirmative. Clinicaltrials.gov confirms that this medical research, which was first publicized on April 4th 2022, is still recruiting subjects. 152 participants need to be enrolled from 2 separate locations."

Answered by AI

Are there any vacancies in this research experiment for willing participants?

"According to the information currently available on clinicaltrials.gov, this medical trial is actively seeking participants as of 9/28/2022. It was initially posted 4 months ago, on April 4th 2022."

Answered by AI

Am I eligible to enrol in this medical experiment?

"This clinical trial is searching for 152 individuals, aged 18-65, with post concussive conditions that have caused PTSD according to the DSM-V. To be eligible for enrollment, these patients must show a PCL-5 score of at least 30 and provide their consent in writing."

Answered by AI

Is the enrollment age limit for this trial extended beyond forty?

"The minimum age for enrollment in this trial is 18, while the maximum permitted age is 65."

Answered by AI

Who else is applying?

What state do they live in?
Texas
California
How old are they?
18 - 65
What site did they apply to?
SoCal Neuroscience Research Unit
Texas A&M Research Center
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

Why did patients apply to this trial?

I want to get better. After trying other prescriptions I am now taking Celebrex, Paroxitine, and Trazadone to quiet my brain so I can sleep. In spite of these I remain jittery all the time, cannot sit completely still without concentrating on it, and had to be taken to a hospital for an anxiety attack a few months ago.
PatientReceived 1 prior treatment
Recent research and studies
~18 spots leftby Jul 2024